AGLE
Aeglea Biotherapeutics, Inc.
Director Anthony G. Quinn bought $83K of Aeglea Biotherapeutics, Inc.
Bought$83,177
$4.86Price
17,121Shares
+171%Stake
What AGLE did for a copier
Prices for AGLE after this filing aren't in yet.
Anthony G. Quinn's record
9 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Dec 1. Filed Tue, Dec 5, 4:04 PM ET, after the close. Not investment advice.